Gene Therapy on Cancer Market is Anticipated to Reach USD 20 Billion, at a Notable 12.6% CAGR by 2035

WiseGuy Reports, Sept. 2025 (Press Release) – The Gene Therapy on Cancer Market Global Outlook:

Gene Therapy on Cancer Market Size, Share & Industry Analysis By Application (Oncology, Hematology, Neurology, Cardiology), By Type of Gene Therapy (Viral Vector-Based Therapies, Non-Viral Vector-Based Therapies, CRISPR-Based Therapies), By Gene Delivery Method (In Vivo, Ex Vivo, Oncolytic Virus Therapy), By Treatment Phase (Preclinical, Clinical Trials, Commercialization) and Regional Forecasts, 2025-2032

Gene Therapy on Cancer Market Future Scope:

The future of the healthcare industry is set to be transformed by technology, innovation, and patient-centered care. Artificial intelligence and machine learning will enhance diagnostics, enabling earlier disease detection and personalized treatment plans. Telemedicine and digital health platforms will expand access to care, particularly in remote areas. Wearable devices and health apps will empower patients to monitor their well-being in real time. Precision medicine, driven by genomics, will create tailored therapies for individuals. Robotics and automation will streamline surgeries and hospital workflows. Sustainability and value-based care will remain key priorities, making healthcare more efficient, affordable, and patient-focused.

Gene Therapy on Cancer Market Overview

Market Overview

The Gene Therapy on Cancer Market is witnessing rapid growth, driven by advances in gene editing technologies, rising cancer prevalence, and increasing investment in research and development. Valued at USD 5.4 billion in 2024, the market is projected to reach USD 6.1 billion in 2025 and expand to USD 20.0 billion by 2035, exhibiting a CAGR of 12.6%. The market is increasingly attracting pharmaceutical companies, biotechnology firms, and healthcare institutions seeking innovative cancer treatment solutions.

Request To Free Sample of This Strategic Report –

https://www.wiseguyreports.com/sample-request?id=616170

Key Market Dynamics

Several factors are propelling the Gene Therapy on Cancer Market forward:

• Growing cancer prevalence: Rising incidence of hematologic and solid tumors globally is driving demand for advanced therapeutic options.
• Advancements in gene editing: Technologies such as CRISPR-Cas9 and TALENs enable precise modification of cancer cells, enhancing treatment efficacy.
• Increased investment in R&D: Pharmaceutical and biotech firms are heavily investing in clinical trials and novel therapy development.
• Favorable regulatory environment: Regulatory support for gene therapies in North America and Europe accelerates product approvals and market entry.
• Rising awareness and acceptance: Healthcare professionals and patients increasingly recognize the potential of gene-based cancer treatments.

These dynamics make the market highly attractive for B2B stakeholders, including contract research organizations, oncology centers, and pharmaceutical manufacturers.

🛒 Buy Now Premium Research Report –

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=616170

Segmental Insights

The Gene Therapy on Cancer Market is segmented by Application, Type of Gene Therapy, Gene Delivery Method, Treatment Phase, and Region:

• Application: Solid tumors, hematologic cancers, and rare cancers.
• Type of Gene Therapy: CAR-T cell therapy, viral vector-based therapy, oncolytic virus therapy, RNA-based therapies, and gene editing approaches.
• Gene Delivery Method: Viral vectors, non-viral vectors, nanoparticles, and ex vivo delivery systems.
• Treatment Phase: Preclinical, clinical trials (Phases I–III), and post-marketing.

These segments allow B2B stakeholders to target therapy development, optimize delivery methods, and address specific patient populations effectively.

Regional Analysis

The Gene Therapy on Cancer Market demonstrates diverse growth patterns across global regions:

• North America: Dominates due to advanced healthcare infrastructure, strong R&D investment, and regulatory support.
• Europe: Germany, UK, France, and Italy lead adoption, driven by clinical trials and reimbursement policies.
• Asia-Pacific: China, Japan, and India witness growth from expanding healthcare access, government support, and rising patient awareness.
• South America: Brazil, Mexico, and Argentina are gradually adopting gene therapy treatments, focusing on clinical research and public-private partnerships.
• MEA: GCC countries and South Africa are emerging markets, with increasing research funding and oncology care expansion.

Competitive Landscape

The Gene Therapy on Cancer Market is highly competitive, with key players focusing on innovative therapies, strategic collaborations, and clinical pipeline expansion:

• Novartis
• Rocket Pharmaceuticals
• Bluebird Bio
• Pfizer
• Adaptimmune Therapeutics
• Celgene
• Bristol Myers Squibb
• Sangamo Therapeutics
• Regenxbio
• Amgen
• Regeneron Pharmaceuticals
• Cellectis
• Gilead Sciences
• ORIC Pharmaceuticals
• AstraZeneca

These companies are investing in CAR-T cell therapy, oncolytic virus development, and gene editing technologies to gain market share and meet the rising demand for personalized oncology solutions.

Market Opportunities

The Gene Therapy on Cancer Market offers significant growth opportunities for B2B stakeholders:

• Innovative CAR-T cell therapies: High specificity and efficacy provide opportunities for pharmaceutical and biotech firms.
• Expanding funding for research: Increased public and private investments support clinical trials and product development.
• Growing patient awareness initiatives: Patient education and advocacy programs enhance market penetration.
• Collaborations with biotech firms: Strategic partnerships accelerate therapy development and commercialization.
• Advancements in gene editing technology: Improved precision and safety encourage adoption across treatment pipelines.

Reasons To Buy The Gene Therapy on Cancer Market Report:

➼ In-depth analysis of the Gene Therapy on Cancer Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Avail This Gene Therapy on Cancer Market Language Pages Here:

がん遺伝子治療市場規模 | Marktanteil der Gentherapie bei Krebserkrankungen | Analyse du marché de la thérapie génique contre le cancer | 암 유전자 치료 시장 분석 | 癌症基因治疗市场概况 | Tendencias del mercado de la terapia génica contra el cáncer

Other Related Reports from WiseGuy Research References

Dumping Syndrome Treatment Market | ダンピング症候群治療市場規模 | Marktanteil der Behandlung des Dumping-Syndroms | Analyse du marché du traitement du syndrome de dumping | 덤핑 증후군 치료 시장 분석 | 倾销综合症治疗市场概况 | Tendencias del mercado del tratamiento del síndrome de dumping

Avanafil Market | アバナフィル市場規模 | Marktanteil von Avanafil | Analyse du marché de l'avanafil | 아바나필 시장 분석 | 阿伐那非市场概览 | Tendencias del mercado de avanafil

Geographic Atrophy Treatment Market | 地理的萎縮治療市場規模 | Marktanteil der Behandlung geografischer Atrophie | Analyse du marché du traitement de l'atrophie géographique | 지리적 위축 치료 시장 분석 | 地图样萎缩治疗市场概况 | Tendencias del mercado del tratamiento de la atrofia geográfica

Peptide Therapy Market | ペプチド療法市場規模 | Marktanteil der Peptidtherapie | Analyse du marché de la thérapie peptidique | 펩타이드 치료제 시장 분석 | 肽疗法市场概况 | Tendencias del mercado de la terapia con péptidos

Enbrel Market | エンブレル市場規模 | Enbrel-Marktanteil | Analyse du marché de l'enbrel | 엔브렐 시장 분석 | 恩利市场概览 | Tendencias del mercado de Enbrel

Duloxetine HCl Market | デュロキセチン塩酸塩の市場規模 | Duloxetin HCL Marktanteil | Analyse du marché du chlorhydrate de duloxétine | 둘록세틴 HCL 시장 분석 | 盐酸度洛西汀市场概览 | Tendencias del mercado del clorhidrato de duloxetina

Hydromorphone Market | ヒドロモルフォン市場規模 | Hydromorphon Marktanteil | Analyse du marché de l'hydromorphone | 히드로모르폰 시장 분석 | 氢吗啡酮市场概览 | Tendencias del mercado de hidromorfona

Cyproheptadine Market | シプロヘプタジン市場規模 | Cyproheptadin Marktanteil | Analyse du marché de la cyproheptadine | 시프로헵타딘 시장 분석 | 赛庚啶市场概览 | Tendencias del mercado de ciproheptadina

Testosterone Enanthate Market | テストステロンエナント酸エステル市場規模 | Marktanteil von Testosteron Enantat | Analyse du marché de l'énanthate de testostérone | 테스토스테론 에난테이트 시장 분석 | 庚酸睾酮市场概览 | Tendencias del mercado del enantato de testosterona

Natural Medicine Market | 天然薬市場規模 | Marktanteil der Naturheilmittel | Analyse du marché de la médecine naturelle | 천연 의약품 시장 분석 | 天然药物市场概况 | Tendencias del mercado de la medicina natural

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets